Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Ophthalmol ; 32(1): 336-340, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34218720

ABSTRACT

PURPOSE: To evaluate structural changes in the anterior chamber and intraocular pressure (IOP) changes following intravitreal dexamethasone implantation. METHODS: Forty-two eyes of 42 patients that received intravitreal dexamethasone implant for the management of macular edema secondary to diabetic retinopathy or branch retinal vein occlusion (BRVO) were included in the study. IOP was measured by Goldmann applanation tonometry. Anterior chamber depth (ACD) and iridocorneal angle (ICA) was measured by a Scheimflug camera (Sirius, CSO, Italy) the day before the injection of the dexamethasone implant and on postoperative day 1, first week, and first month. RESULTS: Mean IOP was 15.14 ± 2.77 mmHg before the procedure and, 15.67 ± 3.70 mmHg, 15.86 ± 3.11 mmHg, 16.21 ± 2.75 mmHg on day 1, first week, and first month following intravitreal dexamethasone implantation, respectively. Mean ICA and ACD were significantly higher in pseudophakic eyes compared to phakic eyes. However, there was no statistically significant change in ICA before and after the procedure (on postoperative day 1, first week, and first month) among both phakic and pseudophakic patients (p = 0.783). Similarly, ACD remained unchanged after the procedure (on postoperative day 1, first week, and first month) compared to the initial measurement (p = 0.802). CONCLUSION: This study confirmed that there was an increase in IOP. However, these changes were not accompanied with a change in ACD or ICA.


Subject(s)
Macular Edema , Retinal Vein Occlusion , Anterior Chamber , Dexamethasone/therapeutic use , Drug Implants/therapeutic use , Glucocorticoids/therapeutic use , Humans , Intraocular Pressure , Intravitreal Injections , Macular Edema/drug therapy , Macular Edema/etiology , Retinal Vein Occlusion/drug therapy , Visual Acuity
2.
Ocul Immunol Inflamm ; 28(1): 86-91, 2020.
Article in English | MEDLINE | ID: mdl-30556792

ABSTRACT

Purpose: To describe posterior segment findings of antiphospholipid syndrome (APS) and compare them with systemic lupus erythematosus (SLE).Methods: A total of 11 patients with primary APS, 29 secondary APS patients, and 29 SLE patients without APS were included. All patients were referred from rheumatology clinic for detailed ophthalmologic examination. When patients had suspicious lesions, fundus fluorescein angiography was performed (n = 56).Results: The most common retinal examination finding was peripheral venous tortuosity (17.5%) in APS, which was not observed in SLE group. Common FFA findings were pigment epithelial window defects (10%) and vascular filling delays (7.5%) in APS, which were observed in 27.5% and 3.5% of patients with SLE consecutively.Conclusion: Venous tortuosity was significantly more in patients with APS. There was no significant difference for other ocular findings between the groups. Ocular complication rate was lower compared to earlier reports, probably due to better management of disease activity with current treatment protocols.


Subject(s)
Antiphospholipid Syndrome/complications , Lupus Erythematosus, Systemic/complications , Retinal Diseases/etiology , Retinal Pigment Epithelium/pathology , Retinal Vein/pathology , Adolescent , Adult , Antiphospholipid Syndrome/diagnosis , Female , Fluorescein Angiography , Humans , Lupus Erythematosus, Systemic/diagnosis , Male , Middle Aged , Retinal Diseases/diagnosis , Slit Lamp Microscopy , Tonometry, Ocular , Visual Acuity , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...